MX2009009743A - Polvos para reconstitucion. - Google Patents

Polvos para reconstitucion.

Info

Publication number: MX2009009743A
Authority: MX; Mexico
Prior art keywords: reconstitution; powders; dispersed; treatment; relates
Prior art date: 2007-03-14

Application number

MX2009009743A

Other languages

English (en)

Spanish (es)

Inventor

Lieven Elvire Colette Baert

Peter Jozef Maria Van Remoortere

Elke Van Gyseghem

Mooter Guy Rene Jaak Van Den

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-14

Filing date

2008-03-14

Publication date

2009-09-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38055251&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009009743(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-14 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2009-09-23 Publication of MX2009009743A publication Critical patent/MX2009009743A/es

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compositions Of Macromolecular Compounds (AREA)

MX2009009743A 2007-03-14 2008-03-14 Polvos para reconstitucion. MX2009009743A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07104082		2007-03-14
PCT/EP2008/053056 WO2008110619A1 (en)	2007-03-14	2008-03-14	Powders for reconstitution

Publications (1)

Publication Number	Publication Date
MX2009009743A true MX2009009743A (es)	2009-09-23

Family

ID=38055251

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX2009009743A MX2009009743A (es)	2007-03-14	2008-03-14	Polvos para reconstitucion.

Country Status (18)

Country	Link
US (1)	US8916558B2 (zh)
EP (1)	EP2043608B1 (zh)
JP (1)	JP5554571B2 (zh)
KR (1)	KR101580297B1 (zh)
CN (1)	CN101636149B (zh)
AP (1)	AP2964A (zh)
AR (2)	AR065720A1 (zh)
AU (1)	AU2008225774B2 (zh)
BR (1)	BRPI0808897B8 (zh)
CA (1)	CA2676981C (zh)
CL (1)	CL2008000746A1 (zh)
ES (1)	ES2535162T3 (zh)
IL (1)	IL199874A (zh)
MX (1)	MX2009009743A (zh)
RU (1)	RU2477133C2 (zh)
TW (1)	TWI494133B (zh)
WO (1)	WO2008110619A1 (zh)
ZA (1)	ZA200906344B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY169670A (en)	2003-09-03	2019-05-08	Tibotec Pharm Ltd	Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI494133B (zh)	2007-03-14	2015-08-01	Tibotec Pharm Ltd	重組用粉末
ES2823805T3 (es) *	2011-04-15	2021-05-10	Janssen Pharmaceutica Nv	Nanosuspensiones de fármacos secadas por congelamiento
JP6301339B2 (ja) *	2012-09-27	2018-03-28	ビーエーエスエフソシエタス・ヨーロピアＢａｓｆＳｅ	少なくとも１種の水溶性ビタミンｅ誘導体および少なくとも１種の親水性ポリマーを含む、保存において安定な無塵の均質な粒子製剤
CN114126655A (zh) *	2019-07-03	2022-03-01	爱尔兰詹森科学公司	用利匹韦林治疗儿科患者的hiv的方法
CN113440529B (zh) *	2020-03-25	2023-11-14	江苏恒瑞医药股份有限公司	一种可注射的药物组合物及其制备方法
CN114392241B (zh) *	2022-01-10	2023-07-25	安徽贝克生物制药有限公司	一种利匹韦林片及其制备方法
TW202406551A (zh) *	2022-04-22	2024-02-16	愛爾蘭商健生科學愛爾蘭無限公司	冷凍乾燥組成物(一)

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3089818A (en) *	1960-06-02	1963-05-14	Baxter Laboratories Inc	Water dispersible antibiotics
US5182111A (en)	1987-11-17	1993-01-26	Boston University Research Foundation	In vivo delivery of active factors by co-cultured cell implants
US5368864A (en) *	1988-11-25	1994-11-29	Henning Berlin Gmbh Chemie- Und Pharmawerk	Formulation of oxypurinol and/or its alkali and alkaline earth salts
US5316773A (en) *	1990-07-19	1994-05-31	Otsuka Pharmaceutical Co., Ltd.	Particulate preparation containing a flourracil derivative and hydroxypropylmethyl-cellulose
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
US5837747A (en)	1991-10-29	1998-11-17	Vivorx, Inc.	Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
AU4079593A (en)	1992-05-13	1993-12-13	Wellcome Foundation Limited, The	Therapeutic combinations
JPH06316524A (ja)	1992-09-11	1994-11-15	Naoyuki Inoue	抗エイズウイルス剤
TW401303B (en)	1994-07-01	2000-08-11	Janssen Pharmaceutica Nv	Anti-HIV triple combination
US6045829A (en)	1997-02-13	2000-04-04	Elan Pharma International Limited	Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
DE60020382T2 (de)	1999-09-21	2006-01-26	Skyepharma Canada Inc., Verdun	Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
IL148801A0 (en)	1999-09-24	2002-09-12	Janssen Pharmaceutica Nv	Antiviral compositions
US6743446B2 (en)	1999-12-15	2004-06-01	The Ohio State University Research Foundation	Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
TW200800298A (en)	2000-01-27	2008-01-01	Zentaris Ag	Compressed microparticles for dry injection
EP1267879A2 (en)	2000-03-30	2003-01-02	Bristol-Myers Squibb Company	Sustained release beadlets containing stavudine
US20040115268A1 (en)	2000-04-26	2004-06-17	Control Delivery Systems, Inc.	Systemic delivery of antiviral agents
DE10050199A1 (de)	2000-10-11	2002-04-25	Ethicon Gmbh	Flächiges Implantat mit im Ultraschall detektierbaren Elementen
CA2431319A1 (en)	2000-12-11	2002-06-20	Hiroto Bando	Pharmaceutical composition having an improved water solubility
PT1404300E (pt)	2001-06-22	2009-11-09	Bend Res Inc	Composições farmacêuticas de dispersões de fármacos e polímeros neutros
JO3429B1 (ar)	2001-08-13	2019-10-20	Janssen Pharmaceutica Nv	مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en)	2003-09-03	2019-05-08	Tibotec Pharm Ltd	Combinations of a pyrimidine containing nnrti with rt inhibitors
AU2002364701B8 (en)	2001-11-20	2006-06-22	Alkermes, Inc.	Compositions for sustained action product delivery
JP4822707B2 (ja)	2002-08-09	2011-11-24	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	４−［［４−［［４−（２−シアノエテニル）−２，６−ジメチルフェニル］アミノ］−２−ピリミジニル］アミノ］ベンゾニトリルの製造方法
WO2004022033A1 (en)	2002-09-04	2004-03-18	Microchips, Inc.	Method and device for the controlled delivery of parathyroid hormone
AU2003291457A1 (en)	2002-11-08	2004-06-03	Glaxo Group Limited	Pharmaceutical antiviral compositions
JP2006508145A (ja)	2002-11-15	2006-03-09	テイボテク・フアーマシユーチカルズ・リミテツド	抗感染化合物としての置換インドールピリジニウム
WO2004050068A1 (en) *	2002-11-29	2004-06-17	Janssen Pharmaceutica N.V.	Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
AP2065A (en)	2003-02-07	2009-11-26	Janssen Pharmaceutica Nv	Pyrimidine derivatives for the prevention of HIV infection
KR100629771B1 (ko)	2004-01-27	2006-09-28	씨제이 주식회사	결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
JP2008501802A (ja)	2004-06-08	2008-01-24	バーテックス　ファーマシューティカルズ　インコーポレイテッド	医薬組成物
MY191349A (en) *	2004-08-27	2022-06-17	Bayer Pharmaceuticals Corp	New pharmaceutical compositions for the treatment of hyper-proliferative disorders
CA2577288C (en)	2004-09-02	2010-11-30	Janssen Pharmaceutica N.V.	Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
JP4912309B2 (ja)	2004-09-02	2012-04-11	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	４−［［４−［［４−（２−シアノエテニル）−２，６−ジメチルフェニル］アミノ］−２−ピリミジニル］アミノ］ベンゾニトリルの塩酸塩
EP2623095A1 (en)	2004-11-16	2013-08-07	Elan Pharma International Limited	Injectable nanoparticulate olanzapine formulations
TWI457136B (zh)	2005-04-04	2014-10-21	Tibotec Pharm Ltd	Ｈｉｖ-感染之預防
US20060269475A1 (en)	2005-04-11	2006-11-30	Ryu Wonhyoung	Multi-layer structure having a predetermined layer pattern including an agent
TW200710091A (en) *	2005-04-11	2007-03-16	Tibotec Pharm Ltd	(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
EP1893180A2 (en)	2005-06-07	2008-03-05	Pfizer Products Inc.	Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
EP1909762A2 (en) *	2005-07-28	2008-04-16	Isp Investments Inc.	Amorphous efavirenz and the production thereof
SG170073A1 (en)	2006-01-20	2011-04-29	Tibotec Pharm Ltd	Long term treatment of hiv infection
SI2029110T1 (sl)	2006-06-06	2012-01-31	Tibotec Pharm Ltd	Z razprĹˇevanjem posuĹˇeni pripravki TMC125
US20090176813A1 (en)	2006-06-23	2009-07-09	Lieven Elvire Colette Baert	Aqueous suspensions of tmc278
WO2008060360A2 (en)	2006-09-28	2008-05-22	Surmodics, Inc.	Implantable medical device with apertures for delivery of bioactive agents
TWI494133B (zh)	2007-03-14	2015-08-01	Tibotec Pharm Ltd	重組用粉末
AU2008274185B2 (en)	2007-07-12	2014-07-03	Janssen Sciences Ireland Uc	Crystalline form of (E) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
WO2009046299A2 (en)	2007-10-04	2009-04-09	Boston Scientific Scimed, Inc	Implantable drug depot for intrathecal drug delivery system for pain management
US20110257111A1 (en)	2008-10-24	2011-10-20	Harbeson Scott L	Hydroxyethlamino Sulfonamide Derivatives

2008
- 2008-03-13 TW TW097108780A patent/TWI494133B/zh active
- 2008-03-13 AR ARP080101032A patent/AR065720A1/es not_active Application Discontinuation
- 2008-03-13 CL CL200800746A patent/CL2008000746A1/es unknown
- 2008-03-14 BR BRPI0808897A patent/BRPI0808897B8/pt active IP Right Grant
- 2008-03-14 AU AU2008225774A patent/AU2008225774B2/en active Active
- 2008-03-14 JP JP2009553156A patent/JP5554571B2/ja active Active
- 2008-03-14 EP EP08717800.0A patent/EP2043608B1/en active Active
- 2008-03-14 WO PCT/EP2008/053056 patent/WO2008110619A1/en active Application Filing
- 2008-03-14 RU RU2009137911/15A patent/RU2477133C2/ru active
- 2008-03-14 AP AP2009004969A patent/AP2964A/xx active
- 2008-03-14 KR KR1020097017592A patent/KR101580297B1/ko active IP Right Grant
- 2008-03-14 CN CN200880008342.0A patent/CN101636149B/zh active Active
- 2008-03-14 CA CA2676981A patent/CA2676981C/en active Active
- 2008-03-14 MX MX2009009743A patent/MX2009009743A/es active IP Right Grant
- 2008-03-14 ES ES08717800.0T patent/ES2535162T3/es active Active
- 2008-03-14 US US12/530,665 patent/US8916558B2/en active Active
2009
- 2009-07-15 IL IL199874A patent/IL199874A/en active IP Right Grant
- 2009-09-11 ZA ZA2009/06344A patent/ZA200906344B/en unknown
2019
- 2019-01-21 AR ARP190100128A patent/AR114086A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR065720A1 (es)	2009-06-24
BRPI0808897A2 (pt)	2014-09-02
EP2043608A1 (en)	2009-04-08
JP5554571B2 (ja)	2014-07-23
RU2009137911A (ru)	2011-04-20
BRPI0808897B8 (pt)	2021-05-25
CN101636149A (zh)	2010-01-27
CA2676981A1 (en)	2008-09-18
BRPI0808897B1 (pt)	2020-10-20
CA2676981C (en)	2015-01-13
ZA200906344B (en)	2015-04-29
AP2009004969A0 (en)	2009-10-31
CL2008000746A1 (es)	2008-09-22
TWI494133B (zh)	2015-08-01
RU2477133C2 (ru)	2013-03-10
KR20090119964A (ko)	2009-11-23
WO2008110619A1 (en)	2008-09-18
AP2964A (en)	2014-09-30
US20100120795A1 (en)	2010-05-13
IL199874A (en)	2016-02-29
ES2535162T3 (es)	2015-05-05
CN101636149B (zh)	2014-08-06
EP2043608B1 (en)	2015-01-21
AU2008225774A1 (en)	2008-09-18
KR101580297B1 (ko)	2015-12-24
US8916558B2 (en)	2014-12-23
AU2008225774B2 (en)	2014-04-10
JP2010520918A (ja)	2010-06-17
TW200911303A (en)	2009-03-16
AR114086A2 (es)	2020-07-22
IL199874A0 (en)	2010-04-15

Legal Events

Date	Code	Title	Description
2015-09-02	FG	Grant or registration

Publication	Publication Date	Title
MY161495A (en)	2017-04-14	Virus like particle compositions and methods of use
MX2009008617A (es)	2009-10-14	Uso de antagonistas de interleucina-23 para el tratamiento de infeccion.
MX2009009743A (es)	2009-09-23	Polvos para reconstitucion.
HK1216880A1 (zh)	2016-12-09	某些***並吡啶化合物、其組合物和它們在治療癌症中的用途
EP2569330A4 (en)	2013-11-13	CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF
RS53124B (en)	2014-06-30	USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY
GEP20156230B (en)	2015-01-26	Forms of rifaximin and usage thereof
PH12014501738A1 (en)	2014-11-10	Piperidino-pyrimidine derivatives for the treatment of viral infections
WO2012076293A9 (de)	2013-03-07	Zubereitungen enthaltend polysiloxane mit stickstoffhaltigen gruppen
MX2022011699A (es)	2022-11-09	Compuestos para tratar la atrofia muscular espinal.
WO2008127364A3 (en)	2008-12-18	Antiviral compounds and use thereof
MX341825B (es)	2016-09-05	Compuestos de heteroarilo y usos de los mismos.
WO2010090860A3 (en)	2011-04-07	Methods and compositions for treating bacterial infection
IN2015DN03327A (zh)	2015-10-09
MX2008001652A (es)	2008-04-07	Copolimeros de poliamonio-polisiloxano.
MX350234B (es)	2017-08-30	Compuestos de enlace especificos de bacterias gram-positivas.
MX352962B (es)	2017-12-15	Compuestos para tratar atrofia muscular espinal.
WO2009129246A3 (en)	2011-03-31	Compositions and methods for preparing and using same
WO2010083385A3 (en)	2010-12-02	Compounds for reducing drug resistance and uses thereof
MX356210B (es)	2018-05-18	Formulaciones de polimero acrilico.
WO2011113060A3 (en)	2012-01-12	Antiviral compounds and methods of use thereof
WO2011160024A3 (en)	2013-07-18	Compounds useful as antiviral agents, compositions, and methods of use
WO2011153460A3 (en)	2012-04-19	Therapeutic amoeba and uses thereof
MX2013007230A (es)	2013-08-15	Sistemas de polimero.
WO2009114461A3 (en)	2009-11-12	Angiotensin (1-7) dosage forms and uses thereof